rs756182128

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBP6_Very_Strong

The NM_014956.5(CEP164):​c.3931A>C​(p.Thr1311Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T1311S) has been classified as Benign.

Frequency

Genomes: 𝑓 0.33 ( 0 hom., cov: 0)
Exomes 𝑓: 0.091 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CEP164
NM_014956.5 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.17

Publications

6 publications found
Variant links:
Genes affected
CEP164 (HGNC:29182): (centrosomal protein 164) This gene encodes a centrosomal protein involved in microtubule organization, DNA damage response, and chromosome segregation. The encoded protein is required for assembly of primary cilia and localizes to mature centrioles. Defects in this gene are a cause of nephronophthisis-related ciliopathies. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2012]
CEP164 Gene-Disease associations (from GenCC):
  • CEP164-related ciliopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • nephronophthisis 15
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, G2P
  • Senior-Loken syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_014956.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0033161342).
BP6
Variant 11-117409800-A-C is Benign according to our data. Variant chr11-117409800-A-C is described in ClinVar as Benign. ClinVar VariationId is 706985.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014956.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEP164
NM_014956.5
MANE Select
c.3931A>Cp.Thr1311Pro
missense
Exon 30 of 33NP_055771.4
CEP164
NM_001440949.1
c.3937A>Cp.Thr1313Pro
missense
Exon 30 of 33NP_001427878.1
CEP164
NM_001440950.1
c.3931A>Cp.Thr1311Pro
missense
Exon 30 of 33NP_001427879.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CEP164
ENST00000278935.8
TSL:1 MANE Select
c.3931A>Cp.Thr1311Pro
missense
Exon 30 of 33ENSP00000278935.3Q9UPV0-1
CEP164
ENST00000533223.1
TSL:1
n.4789A>C
non_coding_transcript_exon
Exon 16 of 16
CEP164
ENST00000957770.1
c.3862A>Cp.Thr1288Pro
missense
Exon 27 of 30ENSP00000627829.1

Frequencies

GnomAD3 genomes
AF:
0.330
AC:
17947
AN:
54340
Hom.:
0
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.299
Gnomad AMI
AF:
0.406
Gnomad AMR
AF:
0.258
Gnomad ASJ
AF:
0.402
Gnomad EAS
AF:
0.276
Gnomad SAS
AF:
0.294
Gnomad FIN
AF:
0.128
Gnomad MID
AF:
0.181
Gnomad NFE
AF:
0.387
Gnomad OTH
AF:
0.358
GnomAD2 exomes
AF:
0.0664
AC:
12067
AN:
181822
AF XY:
0.0624
show subpopulations
Gnomad AFR exome
AF:
0.0474
Gnomad AMR exome
AF:
0.103
Gnomad ASJ exome
AF:
0.0851
Gnomad EAS exome
AF:
0.0942
Gnomad FIN exome
AF:
0.0386
Gnomad NFE exome
AF:
0.0696
Gnomad OTH exome
AF:
0.0944
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0910
AC:
41369
AN:
454522
Hom.:
0
Cov.:
35
AF XY:
0.0933
AC XY:
21743
AN XY:
232980
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0565
AC:
740
AN:
13090
American (AMR)
AF:
0.0858
AC:
1884
AN:
21968
Ashkenazi Jewish (ASJ)
AF:
0.101
AC:
965
AN:
9588
East Asian (EAS)
AF:
0.110
AC:
1124
AN:
10240
South Asian (SAS)
AF:
0.144
AC:
5812
AN:
40240
European-Finnish (FIN)
AF:
0.126
AC:
2968
AN:
23516
Middle Eastern (MID)
AF:
0.0346
AC:
94
AN:
2720
European-Non Finnish (NFE)
AF:
0.0822
AC:
25923
AN:
315380
Other (OTH)
AF:
0.105
AC:
1859
AN:
17780
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.323
Heterozygous variant carriers
0
3287
6574
9860
13147
16434
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
586
1172
1758
2344
2930
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR;InbreedingCoeff
AF:
0.330
AC:
17948
AN:
54384
Hom.:
0
Cov.:
0
AF XY:
0.308
AC XY:
7978
AN XY:
25894
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.298
AC:
4429
AN:
14858
American (AMR)
AF:
0.257
AC:
1201
AN:
4668
Ashkenazi Jewish (ASJ)
AF:
0.402
AC:
523
AN:
1302
East Asian (EAS)
AF:
0.276
AC:
490
AN:
1774
South Asian (SAS)
AF:
0.296
AC:
511
AN:
1728
European-Finnish (FIN)
AF:
0.128
AC:
401
AN:
3142
Middle Eastern (MID)
AF:
0.171
AC:
12
AN:
70
European-Non Finnish (NFE)
AF:
0.387
AC:
9974
AN:
25744
Other (OTH)
AF:
0.355
AC:
273
AN:
768
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.330
Heterozygous variant carriers
0
940
1880
2821
3761
4701
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
226
452
678
904
1130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.282
Hom.:
0

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
Nephronophthisis 15 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.070
BayesDel_addAF
Benign
-0.24
T
BayesDel_noAF
Benign
-0.59
CADD
Benign
0.068
DANN
Benign
0.65
DEOGEN2
Benign
0.0060
T
Eigen
Benign
-0.93
Eigen_PC
Benign
-1.1
FATHMM_MKL
Benign
0.023
N
LIST_S2
Benign
0.20
T
MetaRNN
Benign
0.0033
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.2
L
PhyloP100
-1.2
PrimateAI
Benign
0.27
T
PROVEAN
Benign
-0.95
N
REVEL
Benign
0.036
Sift
Benign
0.23
T
Sift4G
Benign
0.29
T
Varity_R
0.090
gMVP
0.15
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs756182128;
hg19: chr11-117280516;
COSMIC: COSV54038338;
COSMIC: COSV54038338;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.